David Chamberlain

Hyperchip Inc. offers network routing components and systems including Hyperchip FPGA Cores and Architectures. The Hyperchip H40G Router is a 40 Gb/s router over five times less power consuming, over 10 times smaller and a fraction of the cost of incumbents, using industry standard MicroTCA chassis and open-standard interfaces. In the future Hyperchip will extend its offerings from 40Gb/s to 100Gb/s per MicroTCA chassis and per ATCA slot with in-service scaling from a single line card to full non-blocking multi-chassis systems, across the network industry from high-speed access networks to scalable core routers.

Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA.